CDSCO approves AstraZeneca’s anti-complement medicine Eculizumab
Eculizumab is approved in India to manage two rare diseases- Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
rare diseases
East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures and Micro Labs
The funds raised will be utilised to enable several key initiatives like pre-clinical testing of CAR-NK and CAR-gamma delta T cell…
Lupin appoints Claus Jepsen as President of Global Specialty
Claus Jepsen joins Lupin with over 30 years of experience in commercial strategy and portfolio management
Lupin partners with Celnova Pharma to distribute NaMuscla in Argentina and Colombia
NaMuscla (mexiletine) to be commercialised for the treatment of non-dystrophic myotonic disorders in adults
US approves first gene therapy for children with rare genetic disease
Orchard, which was acquired by Japanese pharmaceutical firm Kyowa Kirin for $477.6 million last year, said it will provide details…
Innovations paving the way for drug discovery of rare diseases
Sanjay Vyas, Executive VP and MD, Parexel examines the challenges associated with rare diseases in India, and emphasises on the…
India’s fight against rare diseases needs more focus on awareness and diagnosis: GlobalData
In November 2023, the Indian Union Health Ministry authorised the sale of four generic medications for the treatment of rare…
Our collaborations with Govt of India focus on building resilient healthcare systems
Sylvia Varela, AVP Asia Area, AstraZeneca discusses about the company’s plans to drive market growth, address public health…
Zydus gets Orphan Drug Designation from USFDA for ZYIL1 to treat Cryopyrin Associated Periodic…
Orphan drug designation by USFDA for ZYIL1 provides eligibility for certain development incentives, including tax credits for…
Xentria gets US FDA orphan drug designation for XTMAB-16 in sarcoidosis
The company is focused on developing novel biologics and biosimilars